Afluria (CSL Ltd.) Influenza Virus Vaccine: Label Change - Risk of Fever and Febrile Seizure

The Afluria vaccine (an influenza vaccine) formulated for the Southern Hemisphere has been associated with an increased incidence of fever and febrile seizure among young children (mainly those less than 5 years of age).

Read the full article here: http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm220764.htm

---

Share this page on your favorite Social Bookmarking websites